Bambusa Therapeutics operates as biotechnology company.
Bambusa Therapeutics has raised $90.0M in total funding. The most recent round was Series A. The last funding was announced in February 2025.
Bambusa Therapeutics's investors include RA Capital Management, Redmile Group, Janus Henderson Investors, INCE Capital, Invus.
Bambusa Therapeutics is headquartered in Boston, United States.
Bambusa Therapeutics operates as biotechnology company.
Bambusa Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bambusa Therapeutics — Funding & Investors." VCBacked, February 14, 2025, https://www.vcbacked.co/company/bambusa-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). Bambusa Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/bambusa-therapeutics
{{cite web |title=Bambusa Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bambusa-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated